Upgrade to SI Premium - Free Trial

Needham & Company Cuts Price Target on Medtronic (MDT) to $84 Following 2Q

November 22, 2016 4:07 PM
Needham & Company maintained a Buy rating on Medtronic, Inc. (NYSE: MDT), and cut the price target to $84.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles